Navigation Links
New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets
Date:5/30/2012

FARMINGTON, Conn., May 30, 2012 /PRNewswire-iReach/ -- Global Information Inc is pleased to announce the immediate availability of two new market research reports from Greystone Research Associates examining the markets for Transmucosal Drug Delivery and Systemic Nasal Sprays.

(Photo: http://photos.prnewswire.com/prnh/20120530/CG15754)

Oral Transmucosal Drug Delivery Market
Greystone Research Associates' new market study "Oral Transmucosal Drug Delivery: Products, Players, Markets and Forecasts" is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector.

The report offers a detailed understanding of the products, markets and commercial opportunities for drug delivery films, sprays, lozenges, wafers and orally dissolvable tablets that are designed to be administered into the oral cavity and be absorbed systematically via the oral mucosa.

The permeability of mucous membranes provides a convenient route for the systemic delivery of new and existing therapeutic drugs. Transmucosal delivery offers the potential for once daily dosing of oral drugs and avoids the effects of first pass metabolism. On the provider side, the development of alternative methods of drug administration has improved the ability of physicians to manage specific problems. Practitioners now recognize the rapid onset, relative reliability, and the general lack of patient discomfort when drugs are administered by the transmucosal route.

The report analyzes and evaluates oral transmucosal drug delivery technology platforms and their impact on the market, with market data and forecasts to 2016. It also covers oral transmucosal drug products and pipeline product candidates.

A summary for this report and a free sample of the full document are available at http://www.giiresearch.com/report/grey242925-oral-transmucosal-drug-delivery-products-players.html

Systemic Nasal Sprays Market
Nasal delivery offers the potential for faster onset of action and less frequent dosing relative to oral drugs. As aging population demographics and managed care initiatives drive growth in home health care and self-administration of drug therapies for chronic conditions such as diabetes, arthritis, and hormone replacement therapy, drug developers are showing increased interest in routes of administration that are patient-friendly and cost-effective. Intranasal administration is well positioned to take advantage of these trends and evolve into a significant role in the future of pharmaceutical development and commercialization.

Intranasal delivery will grow at the expense of the predominant drug delivery methods (oral and parenteral), which cannot be readily optimized for the delivery and dosing of a significant portion of biologically derived drug substances.

The report: "Systemic Nasal Sprays: Products, Players, Markets and Forecasts" analyzes nasal spray product strategies, technologies and patch development issues and provides assessments of intranasal systemic drug products, key design factors and strategic device factors, including market data and forecasts to 2016.

An Executive Summary for this report and a free sample of the full document are available at http://www.giiresearch.com/report/grey242924-systemic-nasal-sprays-products-players-markets.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Largest Private Funder Of Melanoma Research Receives Vital Support From Activist Jeffrey Epstein
2. Catheters (Cardiovascular, Specialty, Urological, Neurovascular, and Intravenous) Market Will Reach USD 33.3 Billion Globally in 2017: Transparency Market Research
3. CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence, Even if Not Related to Safety
4. MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan
5. Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting
6. Accuray and the German Cancer Research Center Sign Master Research and Collaboration Agreement
7. USANA Health Sciences Expands Award-Winning Research and Development Team
8. Intermountain Healthcare and Myriad Genetics Enter Into Research Collaboration Agreement
9. BIOCRATES Life Sciences to Launch Waters Xevo® TQ MS Editions for Two of its Well-established Research Kit Products, AbsoluteIDQ® p180 and p150
10. Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting
11. Contract Research Organizations Set to Experience Rapid Growth as Development Costs for New Drugs Continue to Rise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... and PUNE, India , February 22, 2017 ... Market Research, titled, "Automated Radio Synthesis Modules Market: Global Opportunity ... radiosynthesis modules market was worth $20 million in 2015 and ... CAGR of 6.6% from 2016 to 2022. North ... of both market revenues and unit volumes, whereas ...
(Date:2/22/2017)... Research and Markets has announced the ... Molecule (Biologic, Small Molecule Drugs), By Route of Administration (Systemic, ... 2022" report to their offering. ... The global psoriasis drugs market ... This report provides a detailed analysis of the current ...
(Date:2/22/2017)... WASHINGTON , Feb. 22, 2017 The ... in the U.S. Senate and House of Representatives that ... Pharmacy Benefit Managers (PBMs) -- from extracting retroactive direct ... long term care (LTC) pharmacies and the Medicare program. ... Moore Capito (R-WV) and Jon Tester ...
Breaking Medicine Technology:
(Date:2/22/2017)... Fla. (PRWEB) , ... February 22, 2017 , ... ... is just as effective on smaller and sometimes harder to reach ones, according ... were presented at the International Stroke Conference in Houston by Ricardo A. Hanel, ...
(Date:2/22/2017)... ... 22, 2017 , ... The first-ever National Heart Valve Disease ... individuals join together to increase recognition about the risks of heart valve disease ... we mark a nationwide movement to raise awareness about a disease that has ...
(Date:2/22/2017)... ... ... A product of digesting a micronutrient found in soy may hold the key ... while others do not, a University of Pittsburgh Graduate School of Public Health-led study ... some types of “good” gut bacteria when they metabolize isoflavones (micronutrients found in dietary ...
(Date:2/22/2017)... North Carolina (PRWEB) , ... February 22, 2017 , ... ... of cats and 54% of dogs, according to the Association for Pet Obesity Prevention ... disagreed on key pet food issues such as the benefits of corn and grains, ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... Patient Safety, patient advocates stress that the patient context (age, illness and life ... as reasons to mitigate their occurrence. In addition, all too often, ...
Breaking Medicine News(10 mins):